Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websiteforesightbio.com
CategoryBioTech
Phone+1.646.747.9100
Emailadmin@foresightbi...
Employees
Founded2008
DescriptionDrug development company

Offices

New York, USA
50 West 57th Street
15th Floor
New York, NY, 10019
USA

People

Director and Co-Founder
Director and Co-Founder
Director

Funding

TOTAL $17M
FUNDING TOTAL $17M
Seed, 7/2011
$2M
Venture Round, 11/2013
$15M

Tags

Foresight Biotherapeutics

Foresight Biotherapeutics is a clinical-stage drug development company pioneering novel therapies designed to address significant unmet needs in ophthalmology and otolaryngology.

Foresight’s platform Povidone-Iodine (PVP-I) technology represents an important breakthrough in the treatment of ocular and otic inflammation including bacterial, viral and fungal infections. This platform enables PVP-I, a well-characterized broad spectrum antiseptic with no known microbial resistance, to be formulated in combination with a range of anti-inflammatory agents.

Recent Milestones

Videos

Screenshots

Foresight Biotherapeutics screenshot
Above: Homepage
Uploaded: 10/8/13

Sources

  1. SEC (sec.gov) [edit]
  2. SEC (sec.gov) [edit]
Edit This Page
Last Edited 12/20/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy